The mechanism of action is based on the nuclear factor erythroid 2 related factor 2 (Nrf2) signaling pathway, a main antioxidant signaling regulator that could prevent the development of metabolic syndrome and related cardiovascular diseases, as well as the inhibition by TMZ of the KAT enzyme [72]. This evidence concerns the gene NFE2L2 and metabolic syndrome.